[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100471949":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":17,"centralContacts":17,"locations":23,"responsibleParty":43,"collaborators":17,"id":47,"slug":17,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":17,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":17,"enrollmentInfo":55,"targetDuration":17,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":17,"overallStatus":26,"whyStopped":17,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Chulalongkorn University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Care Bundle Group","EXPERIMENTAL","Treatment step by step we have 5 steps STEP 1: Leptospirosis suspected case STEP 2: Investigations STEP 3: Antibiotics within 1 hour after Hemocultures were taken STEP 4: Intravenous Fluid STEP 5: Stage-Base Management of AKI (KDIGO)",[13],"Procedure: Care Bundle",{"label":15,"type":16,"description":17,"interventionNames":17},"Control Group","NO_INTERVENTION",null,[19],{"type":20,"name":21,"description":11,"armGroupLabels":22,"otherNames":17},"PROCEDURE","Care Bundle",[9],[24],{"facility":25,"status":26,"city":27,"state":27,"zip":28,"country":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Chulalongkorn university","RECRUITING","Bangkok","10330","Thailand",{"type":31,"coordinates":32},"Point",[33,34],100.50144,13.75398,{"lat":34,"lon":33},[37],{"name":38,"role":39,"phone":40,"phoneExt":41,"email":42},"Nattachai Srisawat, MD","CONTACT","6622564000","3597","drnattachai@yahoo.com",{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"PRINCIPAL_INVESTIGATOR","Nattachai Srisawat ,M.D.","Assoc. Prof. Dr.Nattachai Srisawat","100471949",false,"NCT05425524","Leptospirosis Care Bundle Study","Leptospirosis Care Bundle Study: A Randomized Controlled Trial","Inclusion Criteria:\n\n* age \\> 18 years\n* Suspicious Leptospirosis including body temperature \\> 38 celcius, Severe myalgia, and exposure to reservoir hospital of flood water.\n* Calf muscle tenderness\n* Conjunctival suffusion\n* Anuria or oliguria and\u002For proteinuria\n* Jaundice\n* Hemorrhagic manifestations (pulmonary and intestine)\n* Meningeal irritation\n* Nausea, vomiting, abdominal pain, diarrhea.\n* Admitted in hospital\n\nExclusion Criteria:\n\n* other infectious disease\n* pregnancy","ALL","18 Years",{"count":56,"type":57},300,"ESTIMATED","INTERVENTIONAL",[60],"NA","So in management of Leptospirosis patients There really is no another approach to treatment. The importance of the problem was acknowledged by the researchers. As a result, this study was performed in order to The Leptospirosis Care Bundle has been used, and has been proved that its use can reduce the risk of acute renal failure.",[63],"Leptospirosis","2025-08-04",{"date":66,"type":67},"2025-08-07","ACTUAL",{"date":69,"type":67},"2019-10-01",{"date":71,"type":57},"2026-12-31",{"name":5,"class":6},1]